BioJapan 2023: Taiwan at the Forefront of Regenerative Medicine
 
BioJapan 2023, Japan's premier three-day biotechnology event, kicked off at the PACIFICO Yokohama Convention Center on October 11th. Around twenty Taiwanese companies and organizations from academia and industry have been exploring opportunities in licensing, investment, clinical trials, sales, and CDMO markets. According to Taiwanese participants, Japan has been actively seeking external collaborations in recent years, particularly in regenerative medicine, which Japan was devoted to.
 
Visit #GlobalBio for more information about #BioJapan and Cell Therapy in Taiwan:
https://lnkd.in/ebz9HVHi
 
#celltherapy #regenerativemedicine #BioJapan2023
UNICOCELL LumiSTAR Biotechnology, Inc. 昱星生物科技 TFBS Bioscience, Inc. Amarex Clinical Research, LLC